Group 1 - The National Public Health and Medical Health Index (980016) increased by 0.86% as of August 15, 2025, with notable gains in constituent stocks such as Zhenhua Cell (688520) up 7.38% and BGI Genomics (688114) up 4.59% [1] - The Medical Health ETF Taikang (159760) rose by 1.23%, with a latest price of 0.66 yuan, and achieved an annualized return of 5.26% over the past three months [1] - CITIC Securities believes that the CXO industry is showing signs of a turning point, with valuation recovery expected to lead to a new development phase, following a period of adjustment due to a cooling investment environment and high base effects from COVID-19 orders [1] Group 2 - As of July 31, 2025, the top ten weighted stocks in the National Public Health and Medical Health Index accounted for 53.05% of the index, including WuXi AppTec (603259) and Hengrui Medicine (600276) [2] - The Medical Health ETF Taikang closely tracks the National Public Health and Medical Health Index, reflecting the market performance of publicly listed companies in the public health and medical health industry in the A-share market [2]

Group 1 - The medical health ETF Taikang (159760) rose by 0.68% as of July 3, 2025, with the index it tracks, the National Certificate Public Health and Medical Health Index (980016), increasing by 1.01% [1] - Key stocks in the sector include Zhenhua Cell (688520) up 19.99%, Huahai Pharmaceutical (600521) up 10.01%, and Changchun High-tech (000661) up 9.05% [1] - The WAIC 2025 event will be held in Shanghai from July 26-28, focusing on innovations in diagnosis and treatment, AI drug development, and featuring over 30 medical products [1] Group 2 - The National Healthcare Security Administration and the National Health Commission issued measures to support the high-quality development of innovative drugs, aiming to transition China from a "generic drug powerhouse" to an "innovative drug stronghold" [2] - The National Certificate Public Health and Medical Health Index reflects the market performance of listed companies in the public health and medical health industry in A-shares [2] - As of May 30, 2025, the top ten weighted stocks in the index accounted for 52.46%, including companies like Heng Rui Medicine (600276) and WuXi AppTec (603259) [2]